Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Friday, Dec. 6, 2013, 134 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $99.28 to $13,815,000.00.
Highlighted Stocks Traded by Insiders:
Invesco Mortgage Capital (IVR) - FREE Research Report King Richard J. who is President & CEO at Invesco Mortgage Capital bought 5,000 shares at $14.44 on Dec. 6, 2013. Following this transaction, the President & CEO owned 61,545 shares meaning that the stake was reduced by 8.84% with the 5,000-share transaction.
The shares most recently traded at $14.70, up $0.26, or 1.77% since the insider transaction. Historical insider transactions for Invesco Mortgage Capital go as follows:
- 24-Week # shares bought: 6,500
The average volume for Invesco Mortgage Capital has been 1.5 million shares per day over the past 30 days. Invesco Mortgage Capital has a market cap of $2.0 billion and is part of the financial sector and real estate industry. Shares are down 26.43% year-to-date as of the close of trading on Friday.
Invesco Mortgage Capital Inc., a real estate investment trust (REIT), focuses on investing in, financing, and managing residential and commercial mortgage-backed securities and mortgage loans. It invests in residential mortgage-backed securities for which a U.S. The stock currently has a dividend yield of 13.79%. The company has a P/E ratio of 6.2. Currently there are 2 analysts that rate Invesco Mortgage Capital a buy, no analysts rate it a sell, and 7 rate it a hold.
Exclusive Offer: Get the latest Stock Analysis on IVR - FREE TheStreet Quant Ratings rates Invesco Mortgage Capital as a
hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, reasonable valuation levels and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and disappointing return on equity. Get the full
Invesco Mortgage Capital Ratings Report from
TheStreet Quant Ratings now.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
DexCom (DXCM) - FREE Research Report Kahn Barbara who is Director at DexCom sold 1,500 shares at $32.63 on Dec. 6, 2013. Following this transaction, the Director owned 49,263 shares meaning that the stake was reduced by 2.95% with the 1,500-share transaction.
The shares most recently traded at $34.54, up $1.91, or 5.54% since the insider transaction. Historical insider transactions for DexCom go as follows:
- 4-Week # shares sold: 46,568
- 12-Week # shares sold: 46,568
- 24-Week # shares sold: 46,568
The average volume for DexCom has been 619,200 shares per day over the past 30 days. DexCom has a market cap of $2.5 billion and is part of the health care sector and health services industry. Shares are up 154.97% year-to-date as of the close of trading on Friday.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. Currently there are 8 analysts that rate DexCom a buy, no analysts rate it a sell, and 5 rate it a hold.
Exclusive Offer: Get the latest Stock Analysis on DXCM - FREE TheStreet Quant Ratings rates DexCom as a
sell. The area that we feel has been the company's primary weakness has been its disappointing return on equity. Get the full
DexCom Ratings Report from
TheStreet Quant Ratings now.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Validus Holdings (VR) - FREE Research Report Carpenter Michael E.A. who is Director at Validus Holdings sold 4,000 shares at $40.05 on Dec. 6, 2013. Following this transaction, the Director owned 302,370 shares meaning that the stake was reduced by 1.31% with the 4,000-share transaction.
The shares most recently traded at $40.06, up $0.01, or 0.02% since the insider transaction. Historical insider transactions for Validus Holdings go as follows:
- 4-Week # shares sold: 2,084
- 12-Week # shares bought: 7,000
- 12-Week # shares sold: 7,754
- 24-Week # shares bought: 7,000
- 24-Week # shares sold: 37,567
The average volume for Validus Holdings has been 711,800 shares per day over the past 30 days. Validus Holdings has a market cap of $3.9 billion and is part of the financial sector and insurance industry. Shares are up 13.94% year-to-date as of the close of trading on Friday.
Validus Holdings, Ltd. through its subsidiaries, provides reinsurance, insurance, and insurance linked securities fund management services in the property, marine, and specialty lines markets worldwide. The stock currently has a dividend yield of 3.05%. The company has a P/E ratio of 12.7. Currently there are 6 analysts that rate Validus Holdings a buy, no analysts rate it a sell, and 1 rates it a hold.
Exclusive Offer: Get the latest Stock Analysis on VR - FREE TheStreet Quant Ratings rates Validus Holdings as a
buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, increase in stock price during the past year and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full
Validus Holdings Ratings Report from
TheStreet Quant Ratings now.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Clorox Company (CLX) - FREE Research Report Britanik Thomas P who is SVP-Chief Marketing Officer at Clorox Company sold 1,400 shares at $92.74 on Dec. 6, 2013. Following this transaction, the SVP-Chief Marketing Officer owned 11,297 shares meaning that the stake was reduced by 11.03% with the 1,400-share transaction.
The shares most recently traded at $95.62, up $2.88, or 3.01% since the insider transaction. Historical insider transactions for Clorox Company go as follows:
- 4-Week # shares sold: 3,521
- 12-Week # shares sold: 6,405
- 24-Week # shares sold: 6,405
The average volume for Clorox Company has been 1.2 million shares per day over the past 30 days. Clorox Company has a market cap of $12.0 billion and is part of the consumer goods sector and consumer durables industry. Shares are up 30.88% year-to-date as of the close of trading on Friday.
The Clorox Company manufactures and markets consumer and professional products worldwide. The stock currently has a dividend yield of 3.06%. The company has a P/E ratio of 21.4. Currently there is 1 analyst that rates Clorox Company a buy, 3 analysts rate it a sell, and 9 rate it a hold.
Exclusive Offer: Get the latest Stock Analysis on CLX - FREE TheStreet Quant Ratings rates Clorox Company as a
buy. The company's strengths can be seen in multiple areas, such as its notable return on equity, revenue growth, increase in stock price during the past year, growth in earnings per share and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full
Clorox Company Ratings Report from
TheStreet Quant Ratings now.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Apollo Global Management (APO) - FREE Research Report Harris Joshua who is Senior Managing Director at Apollo Global Management sold 122,100 shares at $30.14 on Dec. 6, 2013. Following this transaction, the Senior Managing Director owned 625,427 shares meaning that the stake was reduced by 16.33% with the 122,100-share transaction.
The shares most recently traded at $30.28, up $0.14, or 0.46% since the insider transaction. Historical insider transactions for Apollo Global Management go as follows:
- 4-Week # shares bought: 900
- 12-Week # shares bought: 900
- 24-Week # shares bought: 900
- 24-Week # shares sold: 33,810
The average volume for Apollo Global Management has been 1.1 million shares per day over the past 30 days. Apollo Global Management has a market cap of $4.3 billion and is part of the financial sector and financial services industry. Shares are up 72.29% year-to-date as of the close of trading on Friday.
Apollo Global Management, LLC is a publicly owned investment manager. The firm primarily provides its services to pension and endowment funds, institutional investors, individual investors, pooled investment vehicles, and corporations. The stock currently has a dividend yield of 13.21%. The company has a P/E ratio of 7.1. Currently there are 11 analysts that rate Apollo Global Management a buy, no analysts rate it a sell, and 1 rates it a hold.
Exclusive Offer: Get the latest Stock Analysis on APO - FREE TheStreet Quant Ratings rates Apollo Global Management as a
sell. Among the areas we feel are negative, one of the most important has been weak operating cash flow. Get the full
Apollo Global Management Ratings Report from
TheStreet Quant Ratings now.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. Data for this article provided by
Zacks Investment Research
